TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy

Cell Reports

Volumn 12, Issue 10, 2015, Pages 1678-1690

  Fiorillo, Alyson A ^a   Heier, Christopher R ^a   Novak, James S ^a   Tully, Christopher B ^a   Brown, Kristy J ^a,b   Uaesoontrachoon, Kitipong ^a   Vila, Maria C ^a   Ngheim, Peter P ^a   Bello, Luca ^a,d   Kornegay, Joe N ^c   Angelini, Corrado ^d   Partridge, Terence A ^a,b   Nagaraju, Kanneboyina ^a,b   Hoffman, Eric P ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 146B; MICRORNA 31; MICRORNA 374A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

3' UNTRANSLATED REGION; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; BINDING SITE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXON SKIPPING; FEEDBACK SYSTEM; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; REGULATORY MECHANISM; ANIMAL; C57BL MOUSE; DOG; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SKELETAL MUSCLE; TRANSCRIPTION INITIATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; DOGS; DYSTROPHIN; GENE EXPRESSION; HUMANS; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941180028     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.07.066     Document Type: Article

References (58)

1. Beggs A.H., Hoffman E.P., Snyder J.R., Arahata K., Specht L., Shapiro F., Angelini C., Sugita H., Kunkel L.M. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. Hum. Genet. 1991, 49:54-67.
2. Brown K.J., Marathi R., Fiorillo A.A., Ciccimaro E.F., Sharma S., Rowlands D.S., Rayavarapu S., Nagaraju K., Hoffman E.P., Hathout Y. Accurate quantitation of dystrophin protein in human skeletal muscle using mass spectrometry. J. Bioanal. Biomed. 2012, Suppl 7:001.
3. Cacchiarelli D., Incitti T., Martone J., Cesana M., Cazzella V., Santini T., Sthandier O., Bozzoni I. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep. 2011, 12:136-141.
4. Calabia-Linares C., Robles-Valero J., de la Fuente H., Perez-Martinez M., Martín-Cofreces N., Alfonso-Pérez M., Gutierrez-Vázquez C., Mittelbrunn M., Ibiza S., Urbano-Olmos F.R., et al. Endosomal clathrin drives actin accumulation at the immunological synapse. J. Cell Sci. 2011, 124:820-830.
5. Chamberlain J.S., Grant S.G., Reeves A.A., Mullins L.J., Stephenson D.A., Hoffman E.P., Monaco A.P., Kunkel L.M., Caskey C.T., Chapman V.M. Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome. Somat. Cell Mol. Genet. 1987, 13:671-678.
6. Chen Y.W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., Hoffman E.P. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 2005, 65:826-834.
7. Cirak S., Arechavala-Gomeza V., Guglieri M., Feng L., Torelli S., Anthony K., Abbs S., Garralda M.E., Bourke J., Wells D.J., et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 2011, 378:595-605.
8. Clevenger C.V., Plank T.L. Prolactin as an autocrine/paracrine factor in breast tissue. J. Mammary Gland Biol. Neoplasia 1997, 2:59-68.
9. Cooper B.J., Winand N.J., Stedman H., Valentine B.A., Hoffman E.P., Kunkel L.M., Scott M.O., Fischbeck K.H., Kornegay J.N., Avery R.J., et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988, 334:154-156.
10. Dadgar S., Wang Z., Johnston H., Kesari A., Nagaraju K., Chen Y.W., Hill D.A., Partridge T.A., Giri M., Freishtat R.J., et al. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. J. Cell Biol. 2014, 207:139-158.
11. Eisenberg I., Eran A., Nishino I., Moggio M., Lamperti C., Amato A.A., Lidov H.G., Kang P.B., North K.N., Mitrani-Rosenbaum S., et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. USA 2007, 104:17016-17021.
12. Greco S., De Simone M., Colussi C., Zaccagnini G., Fasanaro P., Pescatori M., Cardani R., Perbellini R., Isaia E., Sale P., et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009, 23:3335-3346.
13. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 1997, 3:970-977.
14. Hamrick M.W., Herberg S., Arounleut P., He H.Z., Shiver A., Qi R.Q., Zhou L., Isales C.M., Mi Q.S. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem. Biophys. Res. Commun. 2010, 400:379-383.
15. Heier C.R., Damsker J.M., Yu Q., Dillingham B.C., Huynh T., Van der Meulen J.H., Sali A., Miller B.K., Phadke A., Scheffer L., et al. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol. Med. 2013, 5:1569-1585.
16. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
17. Hoffman E.P., Monaco A.P., Feener C.C., Kunkel L.M. Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science 1987, 238:347-350.
18. Hoffman E.P., Fischbeck K.H., Brown R.H., Johnson M., Medori R., Loike J.D., Harris J.B., Waterston R., Brooke M., Specht L., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N. Engl. J. Med. 1988, 318:1363-1368.
19. Hoffman E.P., Kunkel L.M., Angelini C., Clarke A., Johnson M., Harris J.B. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology 1989, 39:1011-1017.
20. Hoshino S., Ohkoshi N., Ishii A., Shoji S. The expression of dystrophin, alpha-sarcoglycan, and beta-dystroglycan during skeletal muscle regeneration: immunohistochemical and western blot studies. Acta Histochem. 2002, 104:139-147.
21. Ismail N., Wang Y., Dakhlallah D., Moldovan L., Agarwal K., Batte K., Shah P., Wisler J., Eubank T.D., Tridandapani S., et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 2013, 121:984-995.
22. Jeanson-Leh L., Lameth J., Krimi S., Buisset J., Amor F., Le Guiner C., Barthélémy I., Servais L., Blot S., Voit T., Israeli D. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients. Am. J. Pathol. 2014, 184:2885-2898.
23. Kee A.J., Schevzov G., Nair-Shalliker V., Robinson C.S., Vrhovski B., Ghoddusi M., Qiu M.R., Lin J.J., Weinberger R., Gunning P.W., Hardeman E.C. Sorting of a nonmuscle tropomyosin to a novel cytoskeletal compartment in skeletal muscle results in muscular dystrophy. J. Cell Biol. 2004, 166:685-696.
24. Kesari A., Pirra L.N., Bremadesam L., McIntyre O., Gordon E., Dubrovsky A.L., Viswanathan V., Hoffman E.P. Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule. Hum. Mutat. 2008, 29:728-737.
25. Khanna N., Ge Y., Chen J. MicroRNA-146b promotes myogenic differentiation and modulates multiple gene targets in muscle cells. PLoS ONE 2014, 9:e100657.
26. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
27. Komulainen J., Takala T.E., Kuipers H., Hesselink M.K. The disruption of myofibre structures in rat skeletal muscle after forced lengthening contractions. Pflugers Arch. 1998, 436:735-741.
28. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
29. Kuang W., Tan J., Duan Y., Duan J., Wang W., Jin F., Jin Z., Yuan X., Liu Y. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. Biochem. Biophys. Res. Commun. 2009, 378:259-263.
30. Kumar V., Palermo R., Talora C., Campese A.F., Checquolo S., Bellavia D., Tottone L., Testa G., Miele E., Indraccolo S., et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 2014, 28:2324-2335.
31. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
32. Lemaire C., Heilig R., Mandel J.L. Nucleotide sequence of chicken dystrophin cDNA. Nucleic Acids Res. 1988, 16:11815-11816.
33. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
34. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
35. Lu Q.L., Morris G.E., Wilton S.D., Ly T., Artem'yeva O.V., Strong P., Partridge T.A. Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J. Cell Biol. 2000, 148:985-996.
36. Mendell J.R., Rodino-Klapac L.R., Sahenk Z., Roush K., Bird L., Lowes L.P., Alfano L., Gomez A.M., Lewis S., Kota J., et al. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann. Neurol. 2013, 74:637-647. Eteplirsen Study Group.
37. Mittelbrunn M., Gutiérrez-Vázquez C., Villarroya-Beltri C., González S., Sánchez-Cabo F., González M.A., Bernad A., Sánchez-Madrid F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011, 2:282.
38. Nghiem P.P., Hoffman E.P., Mittal P., Brown K.J., Schatzberg S.J., Ghimbovschi S., Wang Z., Kornegay J.N. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. Am. J. Pathol. 2013, 183:1411-1424.
39. Novák J., Vinklárek J., Bienertová-Vašků J., Slabý O. MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. Pediatr. Blood Cancer 2013, 60:1739-1746.
40. Pegoraro E., Schimke R.N., Garcia C., Stern H., Cadaldini M., Angelini C., Barbosa E., Carroll J., Marks W.A., Neville H.E., et al. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology 1995, 45:677-690.
41. Roberts T.C., Blomberg K.E., McClorey G., El Andaloussi S., Godfrey C., Betts C., Coursindel T., Gait M.J., Smith C.I., Wood M.J. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol. Ther. Nucleic Acids 2012, 1:e39.
42. Rosenblatt J.D., Lunt A.I., Parry D.J., Partridge T.A. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell. Dev. Biol. Anim. 1995, 31:773-779.
43. Shimatsu Y., Yoshimura M., Yuasa K., Urasawa N., Tomohiro M., Nakura M., Tanigawa M., Nakamura A., Takeda S. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myol. 2005, 24:145-154.
44. Skog J., Würdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
45. Smith B.F., Yue Y., Woods P.R., Kornegay J.N., Shin J.H., Williams R.R., Duan D. An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab. Invest. 2011, 91:216-231.
46. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
47. Townsend D., Daly M., Chamberlain J.S., Metzger J.M. Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during aging. Mol. Ther. 2011, 19:1821-1825.
48. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
49. Valentine B.A., Cooper B.J., de Lahunta A., O'Quinn R., Blue J.T. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J. Neurol. Sci. 1988, 88:69-81.
50. van den Bergen J.C., Wokke B.H., Janson A.A., van Duinen S.G., Hulsker M.A., Ginjaar H.B., van Deutekom J.C., Aartsma-Rus A., Kan H.E., Verschuuren J.J. Dystrophin levels and clinical severity in Becker muscular dystrophy patients. J. Neurol. Neurosurg. Psychiatry 2014, 85:747-753.
51. van Putten M., Hulsker M., Nadarajah V.D., van Heiningen S.H., van Huizen E., van Iterson M., Admiraal P., Messemaker T., den Dunnen J.T., 't Hoen P.A., Aartsma-Rus A. The effects of low levels of dystrophin on mouse muscle function and pathology. PLoS ONE 2012, 7:e31937.
52. Vignier N., Amor F., Fogel P., Duvallet A., Poupiot J., Charrier S., Arock M., Montus M., Nelson I., Richard I., et al. Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS ONE 2013, 8:e55281.
53. Wernig G., Janzen V., Schäfer R., Zweyer M., Knauf U., Hoegemeier O., Mundegar R.R., Garbe S., Stier S., Franz T., et al. The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment. Proc. Natl. Acad. Sci. USA 2005, 102:11852-11857.
54. Wu B., Lu P., Cloer C., Shaban M., Grewal S., Milazi S., Shah S.N., Moulton H.M., Lu Q.L. Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino. Am. J. Pathol. 2012, 181:392-400.
55. Yokota T., Lu Q.L., Partridge T., Kobayashi M., Nakamura A., Takeda S., Hoffman E. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann. Neurol. 2009, 65:667-676.
56. Yokota T., Nakamura A., Nagata T., Saito T., Kobayashi M., Aoki Y., Echigoya Y., Partridge T., Hoffman E.P., Takeda S. Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs. Nucleic Acid Ther. 2012, 22:306-315.
57. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
58. Zhang X., Azhar G., Wei J.Y. The expression of microRNA and microRNA clusters in the aging heart. PLoS ONE 2012, 7:e34688.